Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 379
Page 379
Appendix C
Workshop Agendas
Workshop on New Prospects and Perspectives on MS Research
November 17-18, 1999
NAS Green Building and Holiday Inn Georgetown
Washington, D.C.
Agenda
Wednesday, November 17
6:00 pm
Henry McFarland
NIH, NINDS
Clinical Picture of MS, including use of imaging in diagnosis and research
7:00 pm
DINNER
Thursday, November 18
8:30 am
Continental breakfast
9:00-9:10 am
Richard Johnston, Chair
National Jewish Medical & Research Center
Introduction
Frontiers In Imaging
9:10-9:25 am
Chien Ho
Carnegie Mellon University
Tracking Immune Cell Migration Through Imaging
OCR for page 380
Page 380
9:40-9:55 am
Scott Fraser
California Inst. Technology
In Vivo Imaging Of Neuronal Development
10:10-10:40 am
General Discussion of Imaging
10:40-11:00 am
BREAK
Risk Factors and Genetic Tools for Research
11:00-11:15 am
Michael Conneally
Indiana University
Identification Of Risk Factors For MS
11:30-11:45 am
John Roder
Mt. Sinai, Univ. Toronto
Inducible Gene Expression In The Nervous System
12:00-12:15 pm
Larry Steinman
Stanford University
Analysis Of Gene Expression Using Microarray Technology
12:30-1:15pm
LUNCH
1: 15-1:45 pm
General Discussion of Genetic Tools
Experimental Therapeutics and Potential Therapeutic Targets
1:45-2:00 pm
Rhona Mirsky
University College, London
Influence Of Schwann Cells On Neural Development And Repair
2: 20-2:40 pm
BREAK
2:40-2:55 pm
Marc Peschanski
INSERM, France
Cell And Gene Therapy For Neurodegenerative Diseases
3:10-3:25 pm
Larry Steinman
Stanford University
Gene Therapy Of Demyelinating Disease
3:40-4:10 pm
General Discussion of Gene Therapy
4:10-5:30 pm
REFRESHMENTS
4:30-4:50 pm
Elliott Kieff
Harvard University
Reflection on the day's discussion through the lens of another field
4:50-5:30 pm
General Discussion
6:30 pm
DINNER
OCR for page 381
Page 381
Workshop on Therapeutic Frontiers: Exploring the Options in MS Research
January 14, 2000
Hyatt Regency
Denver, Colorado
Agenda
Friday January 14
9:00-9:30 am
Continental breakfast
9:30-9:35 am
Richard Johnston, Chair
National Jewish Medical & Research Center
Introduction
9:35-10:15 am
Ole Isacson
Harvard University
Cellular Transplantation in Neurological Disease
10:15-10:30 am
BREAK
10:30-11:15 am
Jeffery Kocsis
Yale University
Neuropharmacological Approaches
11:15-12:00 pm
Joy Snider and Dennis Choi
Washington University, St. Louis
Neuroprotective Strategies
12:00-12:45 pm
LUNCH
12:45-1:30 pm
Jay Siegel
U.S. Food and Drug Administration
FDA Perspectives on Clinical Trials in MS
1:30-2:30 pm
General Discussion
2:30 pm
ADJOURN
OCR for page 382
Page 382
Workshop on Quality of Life
February 23-24, 2000
National Academy of Sciences Building
Washington, D.C.
Agenda
Wednesday, February 23
9:30-10:15 am
Michael Weinrich
NIH, NICHD, National Center for Rehabilitation Research
Rehabilitation Research Strategies
10:15 am
BREAK
10:30-11:15 am
Barbara Vickrey
UCLA
Measuring the Quality of Life
11:15 am - 12:00 pm
Deborah Miller
Cleveland Clinic and Chair, MS Clinical Care Guidelines Committee
The Development and Role of Clinical Care Guidelines
12:00 pm
LUNCH
Thursday, February 24
11:15 am - 12:00 pm
Mindy Aisen
Rehabilitation Research and Development Service, Department of Veterans Affairs
Research to Maximize Function in MS Patients: Rehabilitation and Beyond
OCR for page 383
Page 383
Individuals That Spoke with the Committee About Meeting Patient Needs
January 13, 2000
Hyatt Regency
Denver, Colorado
BRIAN
HUTCHINSON
Executive Vice President and Director of Medical Programs at the Jimmie Heuga Center, which provides medical and educational programs for people with MS
PAT
KENNEDY
Nurse Practitioner, Rocky Mountain MS Center
CHARLOTTE
ROBINSON
Director of Adventures Within, which provides outdoor experience and confidence-building challenges for individuals with MS
ERIC
SIMONS
Consultant and Lecturer on living with MS for Berlex Laboratories, Inc, a subsidiary of Schering AG, Germany
PAM
SORENSEN
Speech Language Pathologist and President of the Consortium of MS Centers
OCR for page 384
Page 384
Representative terms from entire chapter:
gene therapy
